Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.

Ma L, Zhang X, Xiang Q, Zhou S, Zhao N, Xie Q, Zhao X, Zhou Y, Cui Y.

Basic Clin Pharmacol Toxicol. 2018 Aug 13. doi: 10.1111/bcpt.13111. [Epub ahead of print]

PMID:
30103286
2.

[The effect of antipsychotic drug on monoamine receptors in peripheral blood mononuclear cells: affinity linked mechanism].

Taraskina AE, Zabotina AM, Nasyrova RF, Sosin DN, Sosina KA, Ershov EE, Grunina MN, Krupitsky EM.

Biomed Khim. 2018 Mar;64(2):201-207. doi: 10.18097/PBMC20186402201. Russian.

PMID:
29723151
3.

Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia.

Han J, Li Y, Wang X.

Neuropsychiatr Dis Treat. 2017 Dec 5;13:2935-2943. doi: 10.2147/NDT.S148824. eCollection 2017.

4.

Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases.

Sundararajan T, Manzardo AM, Butler MG.

Gene. 2018 Jan 30;641:25-34. doi: 10.1016/j.gene.2017.10.035. Epub 2017 Oct 13.

PMID:
29032150
5.

cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms.

Cosentino M, Kustrimovic N, Ferrari M, Rasini E, Marino F.

Immunology. 2018 Mar;153(3):337-341. doi: 10.1111/imm.12843. Epub 2017 Oct 16.

PMID:
28940477
6.

A computational network analysis based on targets of antipsychotic agents.

Gao L, Feng S, Liu ZY, Wang JQ, Qi KK, Wang K.

Schizophr Res. 2018 Mar;193:154-160. doi: 10.1016/j.schres.2017.07.041. Epub 2017 Jul 26.

PMID:
28755876
7.

Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor.

Błasiak E, Łukasiewicz S, Szafran-Pilch K, Dziedzicka-Wasylewska M.

Pharmacol Rep. 2017 Apr;69(2):235-241. doi: 10.1016/j.pharep.2016.10.016. Epub 2016 Oct 29.

PMID:
28119185
8.

Semi-mechanistic computer simulation of psychotic symptoms in schizophrenia with a model of a humanized cortico-striatal-thalamocortical loop.

Spiros A, Roberts P, Geerts H.

Eur Neuropsychopharmacol. 2017 Feb;27(2):107-119. doi: 10.1016/j.euroneuro.2016.12.006. Epub 2017 Jan 3.

PMID:
28062203
9.

Association study of dopamine receptor genes polymorphisms with the risk of schizophrenia in the Han Chinese population.

Yang B, Niu W, Chen S, Xu F, Li X, Wu X, Cao Y, Zhang R, Yang F, Wang L, Li W, Xu Y, He L, He G.

Psychiatry Res. 2016 Nov 30;245:361-364. doi: 10.1016/j.psychres.2016.08.052. Epub 2016 Aug 25.

PMID:
27591410
10.

Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.

Ferrari M, Comi C, Marino F, Magistrelli L, De Marchi F, Cantello R, Riboldazzi G, Bono G, Cosentino M.

Eur J Clin Pharmacol. 2016 Nov;72(11):1335-1341. Epub 2016 Aug 6.

PMID:
27497990
11.

The role of the dopamine D1 receptor in social cognition: studies using a novel genetic rat model.

Homberg JR, Olivier JD, VandenBroeke M, Youn J, Ellenbroek AK, Karel P, Shan L, van Boxtel R, Ooms S, Balemans M, Langedijk J, Muller M, Vriend G, Cools AR, Cuppen E, Ellenbroek BA.

Dis Model Mech. 2016 Oct 1;9(10):1147-1158. Epub 2016 May 19.

12.

Genetic polymorphisms in dopaminergic system and treatment-resistant schizophrenia.

Terzić T, Kastelic M, Dolžan V, Plesničar BK.

Psychiatr Danub. 2016 Jun;28(2):127-31.

13.

Associations between a locus downstream DRD1 gene and cerebrospinal fluid dopamine metabolite concentrations in psychosis.

Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG.

Neurosci Lett. 2016 Apr 21;619:126-30. doi: 10.1016/j.neulet.2016.03.005. Epub 2016 Mar 5.

14.

Dopamine D1 receptor (DRD1) 5' region haplotypes significantly affect transcriptional activity in vitro.

Yao J, Ding M, Pang H, Xing JX, Xuan JF, Wang BJ.

Neurosci Lett. 2015 Nov 16;609:120-3. doi: 10.1016/j.neulet.2015.10.034. Epub 2015 Oct 17.

PMID:
26484506
15.

Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response.

de Matos LP, Santana CV, Souza RP.

Psychiatry Res. 2015 Sep 30;229(1-2):586-8. doi: 10.1016/j.psychres.2015.07.054. Epub 2015 Jul 21.

PMID:
26213377
16.

The relationship between dopamine receptor D1 and cognitive performance.

Tsang J, Fullard JF, Giakoumaki SG, Katsel P, Katsel P, Karagiorga VE, Greenwood TA, Braff DL, Siever LJ, Bitsios P, Haroutunian V, Roussos P.

NPJ Schizophr. 2015 Mar 4;1:14002. doi: 10.1038/npjschz.2014.2. eCollection 2015. Erratum in: NPJ Schizophr. 2015;1:15018.

17.

Association of dopamine receptor D1 (DRD1) polymorphisms with risperidone treatment response in Chinese schizophrenia patients.

Huo R, Wei Z, Xiong Y, Jiang J, Liu Y, Yan Y, Shi J, Li W, Cui D, Xing Q, He L, Qin S.

Neurosci Lett. 2015 Jan 1;584:178-83. doi: 10.1016/j.neulet.2014.08.041. Epub 2014 Aug 29.

PMID:
25179995
18.

Association of dopamine D1 receptor gene polymorphism with schizophrenia: a meta-analysis.

Pan Y, Yao J, Wang B.

Neuropsychiatr Dis Treat. 2014 Jun 20;10:1133-9. doi: 10.2147/NDT.S63776. eCollection 2014.

19.

Genetic association between the dopamine D1-receptor gene and paranoid schizophrenia in a northern Han Chinese population.

Yao J, Ding M, Xing J, Xuan J, Pang H, Pan Y, Wang B.

Neuropsychiatr Dis Treat. 2014 Apr 17;10:645-52. doi: 10.2147/NDT.S61227. eCollection 2014.

20.

Testosterone induces molecular changes in dopamine signaling pathway molecules in the adolescent male rat nigrostriatal pathway.

Purves-Tyson TD, Owens SJ, Double KL, Desai R, Handelsman DJ, Weickert CS.

PLoS One. 2014 Mar 11;9(3):e91151. doi: 10.1371/journal.pone.0091151. eCollection 2014.

Supplemental Content

Loading ...
Support Center